Cetuximab in Refractory Skin Cancer Treatment

Objectives: Non-melanoma skin cancer is the most common malignancy in US, with an annual incidence of in excess of 1.5 million cases. In the majority of cases, locoregional treatment is curative and systemic therapy is not indicated. Platinum-based chemotherapy regimens have been used most commonly...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalapurakal, Sini J, Malone, James, Robbins, K. Thomas, Buescher, Lucinda, Godwin, John, Rao, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376776/
https://www.ncbi.nlm.nih.gov/pubmed/22712026
http://dx.doi.org/10.7150/jca.3491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376776/
https://www.ncbi.nlm.nih.gov/pubmed/22712026
http://dx.doi.org/10.7150/jca.3491

Ejemplares similares